fbpx

Introducing the TriNav® LV Infusion System

Designed for 3.5 mm to 5.0 mm vessels, the TriNav® LV Infusion System with SmartValve® Technology utilizes the Pressure-Enabled Drug Delivery™ (PEDD™) approach to enhance the T:N ratio for complex patients.1,2
With the inclusion of the TriNav® LV Infusion System, TriSalus now offers a portfolio of TriNav devices to meet your needs in vessel sizes 1.5 mm to 5.0 mm.
Download Specifications

Indications for Use
The TriNav and TriNav LV Infusion Systems are intended for use in angiographic procedures.  They deliver radiopaque media and therapeutic agents to selected sites in the peripheral vascular system.3,4

Contraindications
TriNav and TriNav LV Infusion Systems are not indicated for use in the vasculature of the central nervous system (including the neurovasculature) or central circulatory system (including the coronary vasculature).3,4

Rx Only
For the safe and proper use of the TriNav and TriNav LV Infusion Systems refer to their individual Instructions for Use.

References

1. d’Abadie P, Walrand S, Goffette P, et al. Antireflux catheter improves tumor targeting in liver radioembolization with resin microspheres. Diagn Interv Radiol. 2021;27(6):768-773.

2. Cook K, Gupta D, Liu Y, et al. Real-world evidence of pressure-enabled drug delivery for trans-arterial chemoembolization and radioembolization among patients with hepatocellular carcinoma and liver metastases. Curr Med Res Opin. 2024;40(4):591-598.

3. TriSalusTM TriNav®Infusion System Instructions for Use.

4. TriSalusTM TriNav®LV Infusion System Instructions for Use.